Q-Line Biotech Ltd IPO

Q-Line Biotech Ltd IPO

Trading

sme

Bidding period

21 May 2026 - 25 May 2026

Bid price

₹326.00 - ₹343.00

Listing on

NSE-SME

Listing date

29 May 2026

Lot size

400 shares

Issue size

₹214.48 crore


Minimum investment

₹2,74,400.00 / 2 lot

Maximum investment

₹2,74,400.00 / 2 lot

Bidding closes in 4 days

Open Demat Account
Open Demat Account

Q-Line Biotech Ltd IPO dates

IPO opening date

21 May 2026

IPO end date

25 May 2026

Allotment date

26 May 2026

Initiation of refunds

27 May 2026

Credit of shares to demat

27 May 2026

IPO listing date

29 May 2026

Q-Line Biotech Ltd shareholder pattern

Pre-issue Post-issue
Promoter group 92.24 67.51
Public group 7.76 32.49

Q-Line Biotech Ltd strengths and risks

Information currently unavailable

  • Established manufacturing capabilities with focus on R&D, Reverse Engineering and quality control.

  • Diversified product portfolio with focus on IVD industry.

  • Widespread distribution network with a presence across all four regions.

  • Long standing relationships with customers.

  • Track record of healthy financial performance.

  • Experienced Promoter and Management team.

  • Any disruption, stoppage, slowdown or shutdown in our manufacturing facilities or process or research and development activities could adversely affect our business, financial condition, cash flows and results of operations.

  • Any delay, interruption or reduction in the supply of our raw materials, trade goods from our suppliers and manufacturers both domestic and imported, or an increase in the costs of such raw materials, trade goods may adversely impact the pricing and supply of our products and have an adverse effect on our business, financial condition, cash flows and results of operations.

  • Our business is dependent on the sale of our products through distributors which also include our group entity POCT services. The loss of any of these distributors or third parties for any reason may adversely affect the marketing and distribution of our products and could negatively impact our business, results of operations, financial conditions and cash flows.

  • We are dependent on certain key suppliers to procure a significant portion of our Raw material for production of reagents and for traded machines. Any denial of supplies or loss of the relationship with them could result in disruption in our operations, which could have an adverse effect on our business, financial condition, results of operations and cash flows.

  • We are required to obtain, maintain or renew our statutory and regulatory approvals, licenses, and registrations to operate our business.

  • For manufacturing of our machines and reagents, we are dependent on the agreement with the European companies, any failure to renew the agreement or entering into the agreement on the terms which are not favourable for us may impact our business operations, financial condition and cash flows.

  • Our erstwhile associate company i.e. POCT Science House Private Limited and our promoters namely Saurabh Garg and Amita Garg have been subject to search and seizure operations by the Income-tax Department and any adverse outcome of these proceedings may adversely affect our financial condition.

  • Our operations are concentrated in North India, and any loss of business in such region could have an adverse effect on our business, results of operations and financial condition.

  • Our Company requires a significant amount of working capital for continuing growth. Our inability to meet our working capital requirements may adversely affect our results of operations.

  • We are subject to risks arising from exchange rate fluctuations.

Q-Line Biotech Ltd IPO registrar

Purva Sharegistry (I) Pvt Ltd

Phone number 91 22 2301 2517 / 8261
E-mail ID newissue@purvashare.com
Website www.purvashare.com

Q-Line Biotech Ltd IPO reservation

QIB shares offered

11,88,000 (19.0%)

NII (HNI) shares offered

8,91,600 (14.26%)

Retail shares offered

20,79,200 (33.25%)

Anchor investor shares offered

17,81,200 (28.48%)

Total shares offered

62,53,200

Total shares with anchor investor

62,53,200

Q-Line Biotech Ltd IPO lead manager

  • Hem Securities Limited
  • Share India Capital Services Private Limited

Explore other IPOs

Aarvee Engineering Consultants Limited logo
Aarvee Engineering Consultants Limited logo

Aarvee Engineering Consultants Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Aastha Spintex Limited logo
Aastha Spintex Limited logo

Aastha Spintex Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Absolute Project India Limited logo
Absolute Project India Limited logo

Absolute Project India Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
AceVector Limited logo
AceVector Limited logo

AceVector Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
AceVector Limited logo
AceVector Limited logo

AceVector Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Adroit Industries India Limited logo
Adroit Industries India Limited logo

Adroit Industries India Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Advanced SysTek Limited logo
Advanced SysTek Limited logo

Advanced SysTek Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Advanta Enterprises Limited logo
Advanta Enterprises Limited logo

Advanta Enterprises Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Advit Jewels Limited logo
Advit Jewels Limited logo

Advit Jewels Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Aggcon Equipments International Limited logo
Aggcon Equipments International Limited logo

Aggcon Equipments International Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Agilus Diagnostics Limited logo
Agilus Diagnostics Limited logo

Agilus Diagnostics Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Airox Technologies Limited logo
Airox Technologies Limited logo

Airox Technologies Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Ajay Poly Limited logo
Ajay Poly Limited logo

Ajay Poly Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Alcobrew Distilleries India Limited logo
Alcobrew Distilleries India Limited logo

Alcobrew Distilleries India Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Allchem Lifescience Limited logo
Allchem Lifescience Limited logo

Allchem Lifescience Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Allied Engineering Works Limited logo
Allied Engineering Works Limited logo

Allied Engineering Works Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced

How to apply for an IPO with Bajaj Broking?

adafafds
 
 
  • Log in to the Bajaj Broking trading platform and select ‘IPO’ from the menu.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen IPO.
  • Enter the quantity and your UPI ID.
  • Submit your application—and you're done!

Frequently asked questions

What is the listing date for the Q-Line Biotech Ltd IPO?

The listing date for the Q-Line Biotech Ltd IPO is 29 May 2026.

What is the issue size of Q-Line Biotech Ltd IPO?

The issue size of the Q-Line Biotech Ltd IPO is ₹214.48 cr.

What is the minimum lot size needed for Q-Line Biotech Ltd IPO?

The minimum lot size for Q-Line Biotech Ltd IPO is 400

When does the Q-Line Biotech Ltd open and close?

Q-Line Biotech Ltd IPO is open from 21 May 2026 to 25 May 2026.

How can I apply for the Q-Line Biotech Ltd IPO?

To apply for the Q-Line Biotech Ltd, follow the steps given below:

  • Log in to your Bajaj Broking trading account and navigate to the current IPOs section.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen PO.
  • Enter the quantity and your UPI ID. You will receive a mandate notification to block funds in your UPI app.
SHOW MORE SHOW LESS

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines.
Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.

Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.

Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.

Powered by Bajaj Financial Securities Limited (Bajaj Broking)